AR241159A1 - Un procedimiento para preparar un compuesto de 2-oxindol-1-carboxamida y compuesto obtenido - Google Patents

Un procedimiento para preparar un compuesto de 2-oxindol-1-carboxamida y compuesto obtenido

Info

Publication number
AR241159A1
AR241159A1 AR300259A AR30025985A AR241159A1 AR 241159 A1 AR241159 A1 AR 241159A1 AR 300259 A AR300259 A AR 300259A AR 30025985 A AR30025985 A AR 30025985A AR 241159 A1 AR241159 A1 AR 241159A1
Authority
AR
Argentina
Prior art keywords
compound
oxindol
carboxamide
preparing
procedure
Prior art date
Application number
AR300259A
Other languages
English (en)
Spanish (es)
Other versions
AR241159A2 (es
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR241159A1 publication Critical patent/AR241159A1/es
Publication of AR241159A2 publication Critical patent/AR241159A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR300259A 1984-05-04 1985-05-02 Un procedimiento para preparar un compuesto de 2-oxindol-1-carboxamida y compuesto obtenido AR241159A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
AR241159A1 true AR241159A1 (es) 1991-12-30
AR241159A2 AR241159A2 (es) 1991-12-30

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
AR300259A AR241159A1 (es) 1984-05-04 1985-05-02 Un procedimiento para preparar un compuesto de 2-oxindol-1-carboxamida y compuesto obtenido

Country Status (25)

Country Link
JP (1) JPS60243068A (fi)
KR (1) KR870000497B1 (fi)
AR (1) AR241159A1 (fi)
BG (2) BG60208B2 (fi)
CS (1) CS252828B2 (fi)
DD (1) DD232916A5 (fi)
EG (1) EG17193A (fi)
ES (2) ES8609248A1 (fi)
FI (1) FI80016C (fi)
HU (1) HU196057B (fi)
IE (1) IE851103L (fi)
IN (1) IN161509B (fi)
MA (1) MA20424A1 (fi)
MW (1) MW1685A1 (fi)
MX (1) MX5839A (fi)
NO (1) NO163132C (fi)
OA (1) OA08098A (fi)
PL (2) PL145416B1 (fi)
PT (1) PT80375B (fi)
RO (2) RO94455B (fi)
RU (1) RU2017729C1 (fi)
SU (1) SU1468413A3 (fi)
YU (1) YU44998B (fi)
ZA (1) ZA853324B (fi)
ZW (1) ZW7885A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
PL257892A1 (en) 1986-10-07
AR241159A2 (es) 1991-12-30
HUT37754A (en) 1986-02-28
PL147508B1 (en) 1989-06-30
FI851756L (fi) 1985-11-05
IN161509B (fi) 1987-12-19
CS252828B2 (en) 1987-10-15
DD232916A5 (de) 1986-02-12
PL145416B1 (en) 1988-09-30
KR870000497B1 (ko) 1987-03-12
JPH0335315B2 (fi) 1991-05-27
ES542813A0 (es) 1986-07-16
IE851103L (en) 1985-11-04
MX5839A (es) 1993-11-01
RO91141A (ro) 1987-06-30
YU44998B (en) 1991-06-30
RU2017729C1 (ru) 1994-08-15
HU196057B (en) 1988-09-28
CS320285A2 (en) 1987-03-12
PT80375A (en) 1985-05-01
ES8707182A1 (es) 1987-07-16
FI851756A0 (fi) 1985-05-03
MW1685A1 (en) 1986-09-10
BG60207B2 (en) 1993-12-30
RO91141B (ro) 1987-07-03
NO163132B (no) 1990-01-02
NO163132C (no) 1990-04-11
RO94455A (ro) 1988-06-30
ZA853324B (en) 1986-12-30
YU73085A (en) 1988-04-30
FI80016B (fi) 1989-12-29
MA20424A1 (fr) 1985-12-31
EG17193A (en) 1990-08-30
SU1468413A3 (ru) 1989-03-23
KR850008154A (ko) 1985-12-13
PL253203A1 (en) 1986-06-17
ES551275A0 (es) 1987-07-16
ES8609248A1 (es) 1986-07-16
OA08098A (fr) 1987-03-31
FI80016C (fi) 1990-04-10
ZW7885A1 (en) 1985-07-24
RO94455B (ro) 1988-07-01
JPS60243068A (ja) 1985-12-03
PT80375B (pt) 1987-09-30
BG60208B2 (en) 1993-12-30
NO851774L (no) 1985-11-05

Similar Documents

Publication Publication Date Title
ES540366A0 (es) Un procedimiento para la preparacion de un compuesto
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES551282A0 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
ES545963A0 (es) Procedimiento para la obtencion de un deposito de antibioti-co resorbible
ES557126A0 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES551552A0 (es) Un procedimiento para la preparacion de nuevos compuestos de sulfonilurea
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES544863A0 (es) Un procedimiento para preparar un compuesto de beta-lactama
ES543236A0 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
ES552402A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
ES553602A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas
ES557566A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona
ES542613A0 (es) Un procedimiento para la preparacion de compuesto denominado cl-1724b-2
ES541373A0 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
ES546914A0 (es) Procedimiento para preparar un derivado de (imina ciclica)- difenil-eter
ES546574A0 (es) Procedimiento para preparar derivados de saframicina a
ES551508A0 (es) Un procedimiento para la preparacion de nuevas sulfonilureas
ES557156A0 (es) Un procedimiento para preparar derivados de alcanoles heteropoliciclicos
ES542517A0 (es) Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas
AR241159A1 (es) Un procedimiento para preparar un compuesto de 2-oxindol-1-carboxamida y compuesto obtenido
ES544397A0 (es) Un procedimiento para la preparacion de un compuesto
ES552986A0 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas
ES551129A0 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-pirimidinil- o n-pirazinil-propilaminas
ES542674A0 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina